Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Shares Outstanding (Weighted Average): 2014-2019

Historic Shares Outstanding (Weighted Average) for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to $3.0 million.

  • Soleno Therapeutics' Shares Outstanding (Weighted Average) rose 108.34% to $3.0 million in Q4 2019 from the same period last year, while for Jun 2019 it was $2.1 million, marking a year-over-year increase of 60.74%. This contributed to the annual value of $43.1 million for FY2024, which is 41.37% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Shares Outstanding (Weighted Average) of $3.0 million as of Q4 2019, which was up 40.46% from $2.1 million recorded in Q3 2019.
  • In the past 5 years, Soleno Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $3.0 million in Q4 2019 and a low of $90,255 during Q1 2015.
  • In the last 3 years, Soleno Therapeutics' Shares Outstanding (Weighted Average) had a median value of $1.4 million in 2018 and averaged $1.4 million.
  • Data for Soleno Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 217.48% (in 2019) over the last 5 years.
  • Over the past 5 years, Soleno Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $164,898 in 2015, then grew by 27.45% to $210,155 in 2016, then spiked by 217.30% to $666,820 in 2017, then soared by 114.30% to $1.4 million in 2018, then surged by 108.34% to $3.0 million in 2019.
  • Its Shares Outstanding (Weighted Average) was $3.0 million in Q4 2019, compared to $2.1 million in Q3 2019 and $2.1 million in Q2 2019.